皮肤科非处方药市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00010460
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 279
Buy Now

[研究报告]皮肤科非处方药市场预计将从2021年的154.5663亿美元增长到2028年的213.134亿美元;预计 2021 年至 2028 年复合年增长率为 4.7%。

皮肤科非处方药直接销售给消费者,无需医疗保健专业人士处方,与处方药相反,处方药只能出售给拥有有效处方的消费者。非处方药由监管机构选择,以确保它们含有在没有医生护理的情况下使用时安全有效的成分。非处方药通常根据其活性药物成分 (API) 而不是最终产品进行监管。通过监管 API 而不是具体的药物配方,政府允许制造商自由地将成分或成分组合配制为专有混合物。

战略见解

皮肤科非处方药市场根据产品类型、给药途径、适应症、分销渠道和地理位置进行细分。按地理位置划分,市场大致分为北美、欧洲、亚太地区、中东和非洲 (MEA) 以及南美洲和中美洲。该报告提供了对市场的见解和深入分析,强调市场趋势、技术进步和市场动态等参数,以及对全球领先市场参与者的竞争格局的分析。    

皮肤科非处方药市场利润丰厚的区域


 

市场洞察

皮肤问题的高患病率推动皮肤科非处方药市场增长

皮肤问题的高患病率和中产阶级收入的增加预计将推动全球市场的增长。然而,非处方药的不当使用正在限制皮肤科非处方药市场的增长。皮肤问题,如色素沉着、皱纹、折痕、痤疮和烧伤疤痕,在人们中很常见。根据美国皮肤病学会 (AADA) 的数据,痤疮是美国最常见的皮肤病,每年影响约 5000 万美国人。此外,约 85% 12 至 24 岁的人都经历过轻微的痤疮问题。 2013 年,与痤疮治疗相关的费用和接受痤疮治疗的人的生产力损失超过约 12 亿美元;同年,超过约 510 万人(主要是儿童和年轻人)因痤疮寻求治疗。此外,根据 AADA 的数据,十分之一的人患有特应性皮炎,多达 25% 的儿童和 2-3% 的成人受到影响。 2021 年,Dermstore 对全美 2,000 名女性进行的一项民意调查显示,年轻女性比老年女性更早开始使用产品来减少衰老迹象。此外,欧盟委员会 (EC) 将皮肤病列为人类疾病的第四大常见原因。寻常痤疮在一些国家变得越来越普遍。皮肤科非处方药广泛用于治疗痤疮。了解寻常痤疮负担的特征对于开发有效且有针对性的痤疮控制疗法至关重要。根据 2019 年全球疾病负担研究,全球报告了 1.174 亿寻常痤疮发病病例、2.312 亿流行病例和 500 万伤残调整生命年 (DALY),自 1990 年以来增加了 48%。

人们对皮肤病的认识不断提高,极大地促进了市场的增长

皮肤病极大地影响了人们的生活质量在发展中国家,导致工作和学校生产力下降以及因毁容而受到歧视。皮肤的变化也可能表明存在需要治疗的更严重的疾病。此前,此类疾病被卫生官员忽视或不太重视,因为它们在大多数情况下并不危及生命,而且在三级护理中心很少见。

目前,全国范围内和国际医疗保健中心必须对发展中国家的医疗保健工作者进行培训,以提高皮肤病的诊断和治疗水平。

美国皮肤病学会(AAD)已推出多项公共服务改善皮肤、头发和指甲外观的意识计划。例如,十月是湿疹意识月,AAD 提供皮肤科医生批准的信息,帮助人们更好地了解和管理湿疹。美国皮肤协会 (ASA) 2021 年的资助选项现已推出,用于支持杰出的皮肤病研究人员和医生。在过去 34 年中,ASA 支持了数百项资助,这些资助带来了重要的皮肤病学突破以及对皮肤状况更好的认识和了解。因此,人们对皮肤病的认识不断提高,支持了皮肤科非处方药市场的增长。

             ;

产品类型洞察

根据产品类型,全球皮肤科非处方药市场分为片剂和胶囊、凝胶、乳膏和软膏等。 2021 年,乳霜和软膏细分市场占据最大市场份额。然而,片剂和胶囊细分市场预计在预测期内复合年增长率最高。

给药途径见解

根据给药途径,皮肤科非处方药市场分为外用和口服。 2021年,主题细分市场占据了更大的市场份额;

适应症见解

根据适应症,皮肤科非处方药市场细分为皮炎、痤疮、牛皮癣、皮肤漂白、真菌病、疣等。 2021 年,痤疮细分市场占据最大市场份额;预计在预测期内复合年增长率最高。

分销渠道洞察

根据分销渠道,皮肤科非处方药市场是分为线上发行和线下发行。 2021年,线下分销领域占据了更大的市场份额;然而,预计在线分销领域在预测期内的复合年增长率将更高。此外,线下分销部分分为零售和零售。医院药房和超市超级市场。零售及2021 年,医院药房细分市场占据了更大的市场份额。

皮肤科非处方药市场(按产品类型划分) 2021年-2028年


产品发布、并购是全球皮肤科OTC参与者广泛采用的策略药品市场。下面列出了最近的一些关键产品开发:

2020 年 8 月,全球领先的优质且价格实惠的自我护理产品供应商 Perrigo Company plc 宣布

2018 年 4 月,Sol-Gel Technologies Ltd. 收购了赛诺菲 (Sanofi) 的三个东欧 OTC 护肤和脱发治疗品牌(Emolium、Iwostin 和 Loxon)。一家专注于识别、开发和商业化用于治疗皮肤病的品牌和非专利外用药物产品的临床阶段皮肤病学公司宣布,它已与 Perrigo Company plc 的子公司 Perrigo Israel 合作,开发、制造和商业化通用候选产品。

新冠肺炎 (COVID-19)流行病给全球医疗保健行业带来了沉重负担。随着世界慢慢复苏,企业的经营方式将永远不会一样。 COVID-19 总体上改变了企业格局。多家公司在 2019 年最后一个季度经历了严重亏损,并对 2020 年第一和第二季度产生了负面影响。旨在确定 SARS-CoV-2 病毒对患者威胁的研发活动可能会减缓皮肤科 OTC 的发展药品市场的增长。因此,COVID-19 大流行对皮肤科非处方药市场的影响是直接而剧烈的。由于 COVID-19 的爆发,对皮肤科非处方药的需求减少,因为医疗保健的重点转向了拯救生命。 COVID-19 大流行正在对全球供应链、消费市场和全球经济造成巨大破坏。由于世界各国政府采取的措施,皮肤科非处方药的需求可能会暂时大幅下降。因此,疫情对皮肤科非处方药市场产生了不利影响。

皮肤科非处方药 –市场细分

全球皮肤科非处方药市场根据类型、技术、服务和地理位置进行细分。根据产品类型,市场分为片剂和胶囊、凝胶、乳膏和软膏等。根据给药途径,皮肤科非处方药市场分为外用和口服。根据适应症,皮肤科非处方药市场分为皮炎、痤疮、牛皮癣、皮肤漂白、真菌病、疣等。根据分销渠道,市场分为线上分销和线下分销。皮肤科非处方药市场按地域划分,大致分为北美、欧洲、亚太地区、中东和非洲。非洲、南美洲和中美洲。

公司简介

  • Bausch Health Companies Inc.
  • Perrigo Company plc
  • 拜耳股份公司
  • Viatris Inc.
  • 强生服务公司
  • LEO Pharma A/S
  • 葛兰素史克公司
  • Galderma
  • Dr.雷迪实验室
  • ACELLA PHARMACEUTICALS, LLC
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which is the most influencing segment growing in the dermatology OTC medications report?

The global dermatology OTC medications market-based product type, market is categorized into tablets & capsules, gels, creams & ointments, and others. The creams and ointments segment held the largest share of the market in 2021. However, the tablets and capsules segment is anticipated to register the highest CAGR during the forecast period.

What is the market value of dermatology OTC medications market based on region?

The global dermatology OTC medications market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The US holds the largest share of the market in this region. The market growth in the country is attributed to the increase in skin abnormalities and the rise of availability of medication for dermatology over the counter (OTC) in the region.
The Asia Pacific region is expected to account for the fastest growth in the dermatology OTC medications market. In Japan, India and South Korea, the market is expected to grow owing to the ongoing research activities related to dermatology OTC products in the region.

Who are the major players in the dermatology OTC medications market?

The dermatology OTC medications market majorly consists of the players such as, Bausch Health Companies Inc.; Perrigo Company plc; Bayer AG; Viatris Inc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S; GlaxoSmithKline plc.; Galderma; Dr. Reddy's Laboratories; and Acella Pharmaceuticals, LLC.

What is dermatology OTC medications market?

Dermatology OTC medicines are directly sold by pharmacies and drug stores without the prescription from the physicians, as opposed to the drugs prescribed and maybe only sold to consumers who hold a valid prescription.

What are the factors impacting for the dermatology OTC medications market?

Several factors are believed to affect dermatology OTC medications market in the coming years. Factors such as high prevalence of skin problems and rising income of middle-class population are expected to boost the dermatology OTC medications market. However, the market is likely to get impacted by inappropriate use of OTC medications during the forecast period.

The List of Companies - Dermatology OTC Medications Market

  1. Bausch Health Companies Inc.
  2. Perrigo Company plc
  3. Bayer AG
  4. Viatris Inc.
  5. Johnson and Johnson Services, Inc.
  6. LEO Pharma A/S
  7. GlaxoSmithKline plc.
  8. Galderma
  9. Dr. Reddy's Laboratories
  10. Acella Pharmaceuticals, LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports